健康之路公布招股结果,香港公开发售接获34.42倍认购,一手(500股)中签率50%,认购160手获稳派一手。国际发售录得0.98倍认购。按回补机制,公开发售股份已增至2,500万股,占发售总数13.2%。最终发售价7.8港元,下限定价,集资净额1.09亿港元。股份预期周一(30日)挂牌。
数字健康医疗服务平台健康之路是次全球发售2,500万股,公开发售原占10%。招股价介乎7.8-8.8元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.